Alternatives to Intention-to-Treat Analyses

Pascal Geldsetzer; Till Bärnighausen; Nikkil Sudharsanan

doi:10.1001/jama.2019.3092

Alternatives to Intention-to-Treat Analyses

Pascal Geldsetzer, Till Bärnighausen, Nikkil Sudharsanan

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	2134-2135
Number of pages	2
Journal	JAMA - Journal of the American Medical Association
Volume	321
Issue number	21
DOIs	https://doi.org/10.1001/jama.2019.3092
State	Published - 4 Jun 2019
Externally published	Yes

Access to Document

10.1001/jama.2019.3092

Cite this

@article{87a29ca307fb4adcb263c794adcf5e33,

title = "Alternatives to Intention-to-Treat Analyses",

author = "Pascal Geldsetzer and Till B{\"a}rnighausen and Nikkil Sudharsanan",

note = "Funding Information: Author Affiliations: Department of Biostatistics and Medical Informatics, University of Wisconsin–Madison, Madison. Corresponding Author: David L. DeMets, PhD, Department of Biostatistics and Medical Informatics, University of Wisconsin–Madison, 610 Walnut St, WARF Bldg, Second Floor, Madison, WI 53726 ([email protected]). Conflict of Interest Disclosures: Dr DeMets reported receiving grants from the National Institutes of Health and personal fees from Frontier Science, D. L. DeMets Consulting LLC, Actelion, the Duke Clinical Research Institute, the Population Health Research Institute (Canada), AstraZeneca, GlaxoSmithKline, DalCor, LivaNova, Boston Scientific, Medtronic, the Patient-Centered Outcomes Research Institute, Amgen, Merck, and Sanofi. No other disclosures were reported.",

year = "2019",

month = jun,

day = "4",

doi = "10.1001/jama.2019.3092",

language = "English",

volume = "321",

pages = "2134--2135",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "21",

}

TY - JOUR

T1 - Alternatives to Intention-to-Treat Analyses

AU - Geldsetzer, Pascal

AU - Bärnighausen, Till

AU - Sudharsanan, Nikkil

N1 - Funding Information: Author Affiliations: Department of Biostatistics and Medical Informatics, University of Wisconsin–Madison, Madison. Corresponding Author: David L. DeMets, PhD, Department of Biostatistics and Medical Informatics, University of Wisconsin–Madison, 610 Walnut St, WARF Bldg, Second Floor, Madison, WI 53726 ([email protected]). Conflict of Interest Disclosures: Dr DeMets reported receiving grants from the National Institutes of Health and personal fees from Frontier Science, D. L. DeMets Consulting LLC, Actelion, the Duke Clinical Research Institute, the Population Health Research Institute (Canada), AstraZeneca, GlaxoSmithKline, DalCor, LivaNova, Boston Scientific, Medtronic, the Patient-Centered Outcomes Research Institute, Amgen, Merck, and Sanofi. No other disclosures were reported.

PY - 2019/6/4

Y1 - 2019/6/4

UR - http://www.scopus.com/inward/record.url?scp=85066739317&partnerID=8YFLogxK

U2 - 10.1001/jama.2019.3092

DO - 10.1001/jama.2019.3092

M3 - Letter

C2 - 31162563

AN - SCOPUS:85066739317

SN - 0098-7484

VL - 321

SP - 2134

EP - 2135

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 21

ER -

Alternatives to Intention-to-Treat Analyses

Access to Document

Other files and links

Cite this